Degradation of pyrimidine deoxyribonucleoside triphosphates plays a major role in the regulation of their pool sizes in 3T6 cells. During normal growth, these cells excrete deoxyribonucleosides (mostly deoxyuridine) into the medium. When DNA strand elongation is inhibited, de novo synthesis of dCTP and dTTP continues, followed by degradation of the deoxyribonucleotides. We now demonstrate that inhibition of de novo synthesis with hydroxyurea stops degradation of deoxyribonucleotides and leads to an influx of deoxyuridine from the medium. This effect appears to be caused by a large drop in the size of the intracellular dUMP pool. We propose that substrate cycles, involving phosphorylation of deoxyribonucleosides by kinases and dephosphorylation of deoxyribonucleoside 5'-phosphates by a nucleotidase, participate in the regulation of the size of pyrimidine deoxyribonucleoside triphosphate pools by directing the flow of deoxyribonucleosides across the cell membrane. While kinases are regulated mainly by allosteric effects, the activity of the nucleotidase appears to be regulated by substrate concentration.
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The de novo synthesis of the four deoxyribonucleoside triphosphates (dNTPs), substrates for the replication of DNA, occurs by reduction of ribonucleoside diphosphates (1) (2) (3) . dNTPs can also be formed by a salvage pathway via phosphorylation of the corresponding deoxyribonucleosides when these are available (4) . Key enzymes of both de novo and salvage pathways are subject to complicated allosteric controls. Maintenance of the proper balance between dNTP pools is apparently important for normal cell function, and its perturbation may increase the mutability of cells and have other genotoxic consequences (5, 6) . Enzymes involved in the degradation of dNTPs also participate in the regulation of pools. During normal growth, mouse 3T6 fibroblasts in S phase utilize for DNA synthesis only 75% of the dCDP formed by reduction of CDP and excrete the remaining 25% into the medium as deoxyribonucleosides, mostly as deoxyuridine (7) . When DNA replication is blocked with aphidicolin, dNTP turnover continues and all deoxyribonucleotides synthesized de novo are excreted as deoxyribonucleosides (7) . In contrast, hydroxyurea (8) and azidocytidine (9) inhibitors of ribonucleotide reduction almost completely abolish pyrimidine dNTP turnover. These results suggested the existence of a mechanism regulating the degradation of pyrimidine dNTPs in relation to ongoing dNTP synthesis and DNA replication. Substrate cycles between deoxyribonucleosides and deoxyribonucleotides were suggested to be involved in such a mechanism (7).
Here we explore the possible effects of hydroxyurea on substrate cycles in S-phase 3T6 cells. Treatment with the drug not only blocked the degradation of pyrimidine dNTPs but also resulted in a continued uptake and net phosphorylation of deoxyuridine. This effect was secondary to a large drop in the intracellular dUMP pool. We propose that deoxyuridine and dUMP form a substrate cycle and that the operative direction of this cycle is regulated by the intracellular concentration of dUMP.
MATERIALS AND METHODS
Materials. Deoxy [6-3H] uridine (21 Ci/mmol; l Ci = 37 GBq) was from New England Nuclear Dupont, and [5-3H] cytidine (25) (26) (27) (28) (29) (30) Incorporation of Labeled Nucleosides into Cells. Parallel cultures of 3T6 cells were set up and grown as described (8, 10) . Also the general conditions ofthe experiments, including medium changes, various additions to the media, and the preparation of cells and media for analyses of isotope incorporation into nucleosides, nucleotides, and DNA have been described. Changing the earlier protocol, however, we extracted acid-soluble pools from cells still attached to dishes with 2 ml of 60% methanol for 60 min at 0°C. The methanolic solution was poured off carefully and processed as described (8) . The remaining cells were dissolved in 2 ml of 0.3 M NaOH, kept at room temperature overnight, and used to measure isotope incorporation into DNA.
The size and the specific activity of dNTP pools were determined enzymatically (11) (12) (13) (14) . Isotope incorporation into dUMP and dTMP was measured after separation of the nucleotides by HPLC on Nucleosil C18 columns by isocratic elution with 0.1 M triethylamine phosphate (pH 3.0). HPLC was used also for the separation and analyses of deoxyribonucleosides in the media (7) . The in situ activity of thymidylate synthase was measured by the release of 3H20 into the medium from cells incubated with 5-3H-labeled nucleosides (8, 15, 16 (Fig. 1B) . In the former case, the dCTP pool attained a constant specific activity after 60 min. From there on, the amount of isotope entering dCTP by reduction of CDP equaled the amount leaving the pool to be incorporated into DNA as dCMP plus the amount released into the medium as deoxycytidine, Abbreviations: dNTP, deoxyribonucleoside triphosphate; DP, dipyridamole.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. deoxyuridine, or 3H20. 3H20 arises during the methylation of [5-3H] dUMP and represents the total amount of dTMP formed from dCMP, irrespective of whether dTMP is incorporated into DNA or degraded to thymidine and excreted into the medium. With deoxy [6-3H] uridine, isotope equilibrium was attained more rapidly, the specific activity of dTTP being stable after 15 min. During the steady state, the isotope that left the dTTP pool accumulated as dTMP in DNA and as thymidine in the medium (Fig. 1B) .
Addition of hydroxyurea blocks ribonucleotide reductase (17) (18) (19) and results in an almost immediate cessation of DNA replication. In our experiments we investigated the effect of the drug on the flow of isotope through pyrimidine dNTPs according to the schemes shown in Fig. 1 .
Experiments with [5-3H] Cytidine. In a first experiment (Fig.   2) , we investigated the effects of hydroxyurea on the size of the four dNTP pools and on the turnover of dCTP. During the 60 min of the experiment, both the dATP and dGTP pools decreased continuously in size, while the size of the dCTP pool was halved during the first 10 min and then did not change further (Fig. 2 Left). The dTTP pool expanded and more than doubled. The specific activity of the dCTP pool and its total radioactivity decreased also when the size of the pool no longer changed (Fig. 2 Right). This indicates a slow outflow of isotope from the pool, balanced by resynthesis from a nonlabeled source, possibly deoxycytidine in the medium. Proc. Natl. Acad. Sci. USA 83 (1986) 987
In a second experiment we determined the effect of hydroxyurea on the outflow of isotope from dCTP into the various end products indicated in Fig. LA. Cells were prelabeled for 60 min with cytidine, hydroxyurea was added, and, 10 min after addition of the drug, the labeled medium was replaced with conditioned medium (10) containing cold cytidine and hydroxyurea. During 60 min of continued incubation, we determined the accumulation of isotope in DNA and in the medium as well as the loss of isotope from dCTP. Fig. 3 Left shows the results from the control (no hydroxyurea). Because ofthe presence of a large intracellular prelabeled pool of cytidine phosphates, isotopic dCTP was regenerated continuously also when labeled cytidine was no longer present in the medium. The specific activity of the dCTP pool decreased linearly during the 60-min period, with an average value of 245 cpm/pmol. We used this value to transform the cpm recorded in Fig. 3 into pmol. Thus, a total of 235,000 cpm was incorporated into DNA during 60 min, corresponding to the incorporation of 235,000/245 x 60 = 16 pmol of dCMP per min into DNA. By similar calculations we find that dCTP was degraded to deoxycytidine at a rate of 1.4 pmol/min and to deoxyuridine at a rate of 5.0 pmol/min. Finally, dTMP (= 3H20) was formed from dCMP at a rate of 10 pmol/min. An estimated 10% was degraded (8) and excreted into the medium as thymidine, while the rest was incorporated into DNA. Fig. 3 Right shows the flow of isotope from dCTP into the various end products in the presence of hydroxyurea. In this case the reduction of CDP was blocked, and isotope no longer was incorporated into dCTP. The average specific activity of the dCTP pool during the 60 min in cold medium was 220 cpm/pmol. From the total radioactivity incorporated into the various deoxyribonucleosides in the medium, we calculated that dCTP was degraded to deoxycytidine at a rate of 0.6 pmol/min, to deoxyuridine at a rate of 0.3 pmol/min, and to thymidine at a rate of 1.0 pmol/min. In the calculation of the last value we assumed that all of the dTMP (3H20) was degraded to thymidine, since hydroxyurea had stopped DNA synthesis completely as judged from the insignificant incorporation of dCMP into DNA (data not shown). Fig. 4 , with Fig. 4 Upper representing the two controls; Fig. 4 Lower, the two hydroxyurea sets; Fig. 4 Left, data without DP addition; Fig. 4 Right, data with DP addition.
In the controls, a steady state was rapidly attained, with the specific activity of the dTTP pools reaching values of 1300 cpm/pmol (without DP) and 150 cpm/pmol (with DP). Since the specific activity of deoxyuridine in the medium was known, it was possible to calculate the contribution of the deoxyuridine phosphorylation pathway to total dTTP synthesis simply by dividing the specific activity of the dTTP pool with that of deoxyuridine (17,000 cpm/pmol). We then found that the cells under steady-state conditions synthesized 7.6% (without DP) or 1.4% (with DP) of their dTTP from deoxyuridine.
Also the dUMP and dTMP pools rapidly attained isotopic equilibrium, and we assumed that their specific activities under steady-state conditions were identical to that of the dTTP pool. When we calculated the size of these pools from their total radioactivities as described above, the following values for the 30-min time point were found: dUMP, 15 pmol (without DP) or 32 pmol (with DP); dTMP, 8 pmol (without DP) or 9 pmol (with DP).
The major part of dTTP turnover was accounted for by the incorporation of dTMP into DNA (18.2 pmol/min, irrespective of the presence of DP). A small amount (0.7 pmol/min) was degraded to thymidine. Thus, the total turnover of dTTP was 18.9 pmol/min. Since 7.6% of dTTP originated from (Upper) 3 mM hydroxyurea. During the following 60-min period, we determined incorporation of 3H into DNA, into intracellular dTTP, dTMP, and dUMP, and into extracellular thymidine. The amount of isotope in extracellular thymidine was too low to be measurable in the presence ofdipyridamole. Note the difference in scales in the four panels. ---, dTTP specific activity; -, total radioactivity; *, DNA; o and *, dTTP; o, dThd; v, dUMP; A, dTMP. deoxyuridine, the nucleoside was phosphorylated at a rate of 1.4 pmol/min under steady-state conditions. However, the phosphorylation rate during the first 10 min was faster.
During this time, before isotopic equilibrium had been established, the cells incorporated 214,000 cpm into DNA, 160,000 cpm into dTTP and 12,000 cpm into dTMP and dUMP (Fig. 4 Upper Left). By dividing the sum of these values with 17,000 (the specific activity of deoxyuridine), a phosphorylation rate of 2.3 pmol/min was obtained.
Hydroxyurea prevented the attainment of a steady state, both in the absence (Fig. 4 Lower Left) and presence (Fig. 4 Lower Right) of DP. The specific activity of the dTTP pool increased continuously during the 60 min of the experiment and never reached a plateau value. At all time points, hydroxyurea increased the total amount of radioactivity present as dTTP. This effect was particularly pronounced with DP when the pool, after a 60-min incubation with hydroxyurea, contained about 8 times more isotope than that of the control shown in Fig. 4 Upper Right. A small amount of isotope (12,000 cpm) was incorporated into DNA in the absence of DP during the first 10 min, but from there on incorporation was negligible (data not shown). In the presence of hydroxyurea, the rate of deoxyuridine phosphorylation during the first 10 min was 1.9 pmol/min as compared to the value of 2.3 pmol/min calculated above for the control. However, with hydroxyurea all isotope was incorporated into nucleotide pools and not into DNA. Thus, it appears that the drug caused isotope to accumulate in an expanding dTTP pool instead of flowing through a pool of constant size on its way to DNA.
Calculation of the size of the dTMP and dUMP pools and ofthe rate ofthymidine excretion was complicated by the fact that the cells never reached a steady state in the presence of hydroxyurea. Although it was probable that both dTMP and thymidine rapidly equilibrated their isotope with dTTP and therefore had the same specific activity as dTTP, a similar situation hardly applied to dUMP. In the controls during the steady state, isotope incorporated into dUMP from deoxyuridine was constantly diluted by de novo synthesis of the nucleotide and further channeled into dTTP. Since both dTTP and dUMP turned over rapidly, the specific activity of the two pools soon became identical. The situation changed drastically on addition of hydroxyurea. De novo synthesis of dUMP ceased, and the dUMP pool soon attained the specific activity of deoxyuridine. The dTTP pool was not drained for DNA synthesis but expanded, and it never equilibrated with dUMP. Therefore, in our calculations we assumed that the specific activities of dTMP and thymidine were identical with that of dTTP but that the specific activity of dUMP equaled that of deoxyuridine in the medium. In this way we obtained the following values for the 30-min time point in the presence of hydroxyurea: thymidine excretion, 0.5 pmol/min; dUMP pool, 0.3 pmol (without DP) and 0.08 pmol (with DP); and dTMP pool, 10 pmol (without DP) and 8 pmol (with DP).
The results concerning the effect of hydroxyurea on the size of nucleotide pools are summarized in the first three columns of Table 1 . The most pronounced effect of the drug was a large decrease in the size of the dUMP pool. We might point out that, with the different assumption that dUMP had the same specific activity as dTTP, the size of the dUMP pool would have been 2.3 pmol in the presence of hydroxyurea, a decrease of more than 83% compared to the control. It is evident that, irrespective ofour assumptions, the drug caused a large decrease in dUMP pool size.
The kinetics of the expansion of the dTTP pool caused by addition of hydroxyurea were strongly influenced by DP (Fig.  5) . Without DP, the size of the dTTP pool reached a plateau value after 10 min and decreased slightly between 30 and 60 min. In the presence of DP, the pool expanded slowly and continued its increase up to 60 min. A likely explanation for this behavior is that the increase in pool size largely depended on the phosphorylation of exogenous deoxyuridine and that DP slowed down the internalization of the deoxyribonucleoside. The difference between the two curves reflects on the rate of deoxyuridine phosphorylation and gives a rate of 4.7 pmol/min during the first 10 min. This value is higher than the rate calculated above from isotope data.
DISCUSSION
3T6 cells obtain their supply of dCTP and dTTP mainly by the reduction of CDP (7, 8) . Somewhat surprising, we found that the synthesis of dNTPs during S phase was larger than their demand for DNA synthesis and that the cells degraded the surplus material to deoxyribonucleosides (7) . When DNA replication was inhibited, dNTP synthesis continued and all material was degraded and excreted (7) . The present work illustrates the reverse situation: when de novo synthesis is inhibited, degradation of dNTPs decreases greatly and deoxyribonucleosides are imported into the cell from the medium.
To explain these phenomena, we propose that substrate cycles between deoxyribonucleosides and their 5' phosphates regulate the degradation of pyrimidine dNTPs and the direction of flow of deoxyribonucleosides across the cell membrane. In general, substrate cycles provide a sensitive mechanism for the control of metabolic pathways. Their participation in various aspects of carbohydrate metabolism is well established, but substrate cycles also appear to function in the control of many other metabolic pathways (21, 22) , and the recent demonstration of an adenosine/AMP cycle in hepatocytes (23) is of particular interest in connection with our work.
A model for the participation of a substrate cycle in the regulation of pyrimidine dNTP metabolism is presented in Fig. 6 (26, 27) . Intracellular degradation leads to export of deoxyribonucleosides, whereas intracellular phosphorylation leads to import of deoxyribonucleosides.
Previous work (7, 8) Our experiments with hydroxyurea provide some insight into the regulation of substrate cycles, in particular the one involving deoxyuridine/dUMP. (i) Hydroxyurea blocks the excretion of deoxyuridine, while deoxycytidine and thymidine are less affected. Since deoxyuridine is the major excretion product, the net effect of hydroxyurea is a depression of dNTP degradation. (ii) Hydroxyurea increases the intracellular dTTP pool, largely at the expense of extracellular deoxyuridine. This effect is not caused by an increased phosphorylation of deoxyuridine but by a decreased dephosphorylation of dUMP. The expanding dTTP pool actually causes a feedback-inhibition of thymidine kinase, the enzyme responsible for the phosphorylation of deoxyuridine. The experiments with DP show that the permeation system is not affected by hydroxyurea but that it is required for the expansion of the dTTP pool-i.e., dTTP is synthesized from extracellular deoxyuridine. (iii) The decreased dephosphorylation of dUMP results from a large decrease in the size of the dUMP pool.
Two kinds of enzyme participate in the substrate cycle illustrated in Fig. 6 : a kinase and a nucleotidase. Pyrimidine deoxyribonucleoside kinases are well-known enzymes (4, (28) (29) (30) (31) . Their activity is regulated allosterically. Less is known about the nature of the nucleotidase. A major conclusion from the present work is that the in situ activity of the enzyme degrading dUMP is regulated by substrate concentration. Also the decreased excretion of deoxycytidine after addition of hydroxyurea can be explained by a parallel decrease in nucleotide concentration.
Mammalian cells contain a cytosolic nucleotidase with a preference for deoxyribonucleotides, which has been described and studied in detail by Fritzon (32) . This enzyme has Km values for deoxyribonucleotides in the 10-3 M range. It is present in 3T6 cells (33) and appears to be an excellent candidate for the nucleotidase activity of the substrate cycle.
No evidence was obtained for an allosteric control of this enzyme by dNTPs (L. Hoglund and P.R., unpublished data), but its high Km value for dNMPs would make the enzyme exquisitely sensitive to changes in substrate concentration.
Our experiments concern pyrimidine dNTPs. A control of the size of purine dNTP pools by catabolic enzymes some time ago was illuminated dramatically by the finding that certain immune deficiency diseases in man are caused by the genetic loss of adenosine deaminase or purine nucleoside phosphorylase (34) . It is possible that substrate cycles also may be involved in the regulation of purine dNTPs.
